Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
NVNO enVVeno Medical
6.230-0.070-1.11%
Close
02/03 16:00 ET
6.2300.0000.00%
Post Mkt Price 02/03 19:38 ET
High
6.300
Open
6.200
Turnover
76.10K
Low
6.112
Pre Close
6.300
Volume
12.26K
Post-Market
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
EnVVeno Medical (NASDAQ:NVNO) Trading 6.9% Higher
enVVeno Medical Corporation (NASDAQ:NVNO – Get Rating)'s share price traded up 6.9% on Wednesday . The company traded as high as $6.04 and last traded at $6.02. 14,073 shares traded hands during trad
Critical Review: EnVVeno Medical (NASDAQ:NVNO) Versus PAVmed (NASDAQ:PAVM)
enVVeno Medical (NASDAQ:NVNO – Get Rating) and PAVmed (NASDAQ:PAVM – Get Rating) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on
Head-To-Head Analysis: PAVmed (NASDAQ:PAVM) and EnVVeno Medical (NASDAQ:NVNO)
PAVmed (NASDAQ:PAVM – Get Rating) and enVVeno Medical (NASDAQ:NVNO – Get Rating) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the
EnVVeno Medical Appoints Hamed Alavi as SVP, CTO
EnVVeno Medical Promotes Dr. Hamed Alavi to Senior Vice President and Chief Technology Officer
Analyzing Apyx Medical (NASDAQ:APYX) & EnVVeno Medical (NASDAQ:NVNO)
enVVeno Medical (NASDAQ:NVNO – Get Rating) and Apyx Medical (NASDAQ:APYX – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two companies base
JTC Team to Host the Virtual Investor 2023 Companies to Watch Event on January 17th, 18th, and 19th
- Live video webcast presentations with participating companies -FRENCHTOWN, NJ / ACCESSWIRE / January 11, 2023 / JTC Team ("JTC"), a fully integrated corporate communications and investor relations f
EnVVeno Medical (NASDAQ:NVNO) Trading Down 2%
enVVeno Medical Corporation 's(NASDAQ:NVNO ) share price dropped 2% during trading on Monday.
EnVVeno Medical Announces Presentation of Three-year VenoValve Data
3-Year VenoValve First-In-Human Data Presented At 49th Annual VEITH Symposium On Vascular And Endovascular Issues
First-in-Human VenoValve recipients continue to benefit from VenoValve at average of 3 years post-surgeryNo venous ulcer recurrences or CVI relapsesStability in improvements for all study endpoints in
Company Overview
More
enVVeno Medical Corp. is a development stage medical device company, which develops tissue based solutions that are designed to be life sustaining or life enhancing for patients with cardiovascular disease, and peripheral arterial and venous disease. Its products include The Bioprosthetic Heart Valve, The CoreoGraft, and The Venous Valve. The company was founded by Norman Jaffe on December 22, 1999 and is headquartered in Irvine, CA.
CEO： Mr. Robert A. Berman
Market： NASDAQ
Listing Date： 05/31/2018
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet